{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T14:56:18Z","timestamp":1786460178589,"version":"build-2736575974"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"ABSTRACT<\/jats:title>\n \n Objective:<\/jats:title>\n The objective of this review is to investigate overall survival in patients with human papillomavirus positive oropharyngeal squamous cell carcinoma (HPV+ OPSCC) comparing standard- versus reduced-dose radiotherapy.<\/jats:p>\n <\/jats:sec>\n \n Introduction:<\/jats:title>\n The improved survival of patients with HPV+ compared to HPV-negative OPSCC has raised the question of reducing the total radiation treatment dose delivered to patients with HPV+ OPSCC. A de-escalated radiotherapy protocol may provide equal oncological benefit, with reduced adverse events\/toxicity.<\/jats:p>\n <\/jats:sec>\n \n Inclusion criteria:<\/jats:title>\n We will include any adult patients aged 18years or older who have undergone curative intent treatment for HPV+ OPSCC. These patients can be at any stage at the time treatment is initiated. Exclusion criteria are as follows: pre-clinical or animal studies, patients with non-squamous cell carcinoma lesions of the oropharynx, patients with primary lesions in other head and neck sites, or patients receiving palliative treatment.<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n A three-step search strategy will be used to identify relevant articles for inclusion through MEDLINE, CINAHL, Embase, Web of Science, Scopus, and gray literature sources. These articles will be assessed against our inclusion and exclusion criteria at the title and abstract level as well as at full-text level. Remaining studies will be critically appraised based on their trial design. Data extraction will occur for all studies and, where possible, will be pooled with statistical meta-analysis.<\/jats:p>\n <\/jats:sec>\n \n Systematic review registration number:<\/jats:title>\n PROSPERO CRD42021252161<\/jats:p>\n <\/jats:sec>","DOI":"10.11124\/jbies-21-00159","type":"journal-article","created":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T10:00:39Z","timestamp":1635242439000},"page":"1135-1141","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Effectiveness of reduced- versus standard-dose radiotherapy on survival and radiation-associated toxicity in patients with human papillomavirus\u2013associated oropharyngeal squamous cell carcinoma: a systematic review protocol"],"prefix":"10.11124","volume":"20","author":[{"given":"Timothy J.","family":"Lee","sequence":"first","affiliation":[{"name":"School of Public Health, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giri","family":"Krishnan","sequence":"additional","affiliation":[{"name":"The Department of Otolaryngology, Head and Neck Surgery, The University of Adelaide, Adelaide, SA, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eng H.","family":"Ooi","sequence":"additional","affiliation":[{"name":"College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy H.","family":"Barker","sequence":"additional","affiliation":[{"name":"JBI, The University of Adelaide, Adelaide, SA, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,4]]},"reference":[{"issue":"(5)","key":"R1-20250613","doi-asserted-by":"crossref","first-page":"822","DOI":"10.3201\/eid2005.131311","article-title":"Human papillomavirus prevalence in oropharyngeal cancer before vaccine introduction, United States","volume":"20","author":"Steinau","year":"2014","journal-title":"Emerg Infect Dis"},{"issue":"(11)","key":"R2-20250613","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.3201\/eid1611.100452","article-title":"Oropharyngeal cancer epidemic and human papillomavirus","volume":"16","author":"Ramqvist","year":"2010","journal-title":"Emerg Infect Dis"},{"issue":"(1)","key":"R3-20250613","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang","year":"2010","journal-title":"N Engl J Med"},{"issue":"(15)","key":"R4-20250613","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1016\/j.ejca.2014.07.001","article-title":"De-escalation treatment protocols for human papillomavirus-associated oropharyngeal squamous cell carcinoma: a systematic review and meta-analysis of current clinical trials","volume":"50","author":"Masterson","year":"2014","journal-title":"Eur J Cancer"},{"issue":"(12)","key":"R6-20250613","first-page":"Cd012939","article-title":"De-intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transo-ral minimally invasive surgery for resectable HPV-positive oropharyngeal carcinoma","volume":"12","author":"Howard","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"(3)","key":"R7-20250613","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1177\/107327481602300302","article-title":"Management of oropharyngeal cancer in the HPV era","volume":"23","author":"Naghavi","year":"2016","journal-title":"Cancer Control"},{"issue":"(4)","key":"R8-20250613","first-page":"E171","article-title":"Practice patterns and outcomes following radiation dose de-escalation for oropharyngeal cancer","volume":"130","author":"White","year":"2020","journal-title":"Laryngoscope"},{"issue":"(5)","key":"R9-20250613","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/ijc.30516","article-title":"Diagnostic accuracy of p16(INK4a) immunohistochemis-try in oropharyngeal squamous cell carcinomas: a systematic review and meta-analysis","volume":"140","author":"Prigge","year":"2017","journal-title":"Int J Cancer"},{"issue":"(5)","key":"R10-20250613","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/hed.22015","article-title":"Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer-systematic review and meta-analysis of trends by time and region","volume":"35","author":"Mehanna","year":"2013","journal-title":"Head Neck"},{"issue":"(7)","key":"R11-20250613","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1148\/rg.2019190007","article-title":"Advances in diagnosis and multidisciplinary management of oropharyngeal squamous cell carcinoma: state of the art","volume":"39","author":"Parvathaneni","year":"2019","journal-title":"Radiographics"},{"issue":"(6)","key":"R13-20250613","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","article-title":"The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM","volume":"17","author":"Edge","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"(2)","key":"R14-20250613","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3322\/caac.21389","article-title":"Head and neck cancers-major changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Lydiatt","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"(1)","key":"R15-20250613","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","article-title":"Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients","volume":"92","author":"Pignon","year":"2009","journal-title":"Radio-ther Oncol"},{"issue":"(6)","key":"R16-20250613","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1002\/hed.26642","article-title":"Low-risk human papilloma virus positive oropharyngeal cancer with one positive lymph node: equivalent outcomes in patients treated with surgery and radiation therapy versus surgery alone","volume":"43","author":"Sample","year":"2021","journal-title":"Head Neck"},{"issue":"(1)","key":"R17-20250613","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41572-019-0064-5","article-title":"Radiotherapy toxicity","volume":"5","author":"De Ruysscher","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"R20-20250613","doi-asserted-by":"crossref","first-page":"104608","DOI":"10.1016\/j.oraloncology.2020.104608","article-title":"De-intensification of therapy in human papilloma-virus associated oropharyngeal cancer: a systematic review of prospective trials","volume":"103","author":"Patel","year":"2020","journal-title":"Oral Oncol"},{"key":"R21-20250613","doi-asserted-by":"crossref","first-page":"103243","DOI":"10.1016\/j.critrevonc.2021.103243","article-title":"Decreasing treatment burden in HPV-related OPSCC: a systematic review of clinical trials","volume":"160","author":"lorio","year":"2021","journal-title":"Crit Rev Oncol Hematol"},{"issue":"(1)","key":"R24-20250613","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/XEB.0000000000000152","article-title":"The development of software to support multiple systematic review types: the Joanna Briggs lnstitute System for the Unified Management, Assessment and Review of Information (JBI SUMARI)","volume":"17","author":"Munn","year":"2019","journal-title":"Int J Evid Based Healthc"},{"issue":"(7)","key":"R25-20250613","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"The PRISMA Group; Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"R26-20250613","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"R27-20250613","first-page":"355.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","author":"Sterne","year":"2016","journal-title":"BMJ"},{"issue":"(3)","key":"R28-20250613","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/XEB.0000000000000065","article-title":"Fixed or random effects meta-analysis? Common methodological issues in systematic reviews of effectiveness","volume":"13","author":"Tufanaru","year":"2015","journal-title":"In J Evid Based Healthc"},{"key":"R29-20250613","doi-asserted-by":"crossref","first-page":"l6890","DOI":"10.1136\/bmj.l6890","article-title":"Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline","volume":"368","author":"Campbell","year":"2020","journal-title":"BMJ"}],"container-title":["JBI Evidence Synthesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.11124\/JBIES-21-00159","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T12:34:26Z","timestamp":1786451666000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.11124\/JBIES-21-00159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,25]]},"references-count":23,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.11124\/jbies-21-00159","relation":{},"ISSN":["2689-8381"],"issn-type":[{"value":"2689-8381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,25]]}}}